Crexy Gel for Eyelash and Eyebrow
The formula includes 7 Plate-Like Growth Factors particularly effective in their stimulating action on hair growth for longer and thicker eyelashes and eyebrows. 3 Hyaluronic Acids: 1 to penetrate the hair filling the area of the cortex, 2 and 3 which are positioned between the scales of the cuticle. They favor the external restructuring of the hair making it smoother and strengthening it against the stress of make-up and especially of cleansing.
The characterizing ingredient is also Acetyl Tetrapeptide-3, which favors the anchoring of the hair to the skin and promotes the increase in the size of the hair follicle. Thus it promotes the growth of thicker eyelashes and brows.
It is a gel dedicated to those with short and thin eyelashes and sparse eyebrows. Specifically formulated to promote the growth of eyelashes and eyebrows, it promotes their lengthening and thickness.
The Crexy Gel for eyelash and eyebrow formula is characterized by a light texture, which does not weigh down, spreads easily and dries quickly. Given its structural properties it is excellent as a primer: it increases the yield of the mascara and facilitates its application.
Technology
The skin is difficult to permeate. To penetrate its different levels, Labo researchers have developed a “transdermal” technology. It is based on the molecules of active substances that penetrate the skin layers that allow the effectiveness of the treatment.
The percentages reported refer to the 24-hour transdermal penetration of the active molecules, obtained with the new Labo technology and experimentally tested using Franz Cells.
Eyelashes and Eyebrows
In the scenography of the face, a fundamental role is played by the gaze, which can be enhanced, diminished and saddened by sparse and sparse eyelashes and eyebrows.
Thick and long lashes, thick, strong and defined brows help to accentuate the eyes. They shape the face and enhance communication and expressiveness, especially when the gaze is in the foreground.
Reviews
There are no reviews yet.